February 1, 2000Journal of Clinical Oncology796 citations
Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
View Full Paper
Key Points
Key points are not available for this paper at this time.
Abstract
Hyper-CVAD therapy is superior to our previous regimens and should be compared with established regimens in adult ALL.
Cite This Study
Kantarjian et al. (2000) studied this question.